Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ovid Therapeutics Inc. - Common Stock (NQ:OVID)

1.245 -0.015 (-1.19%)
Streaming Delayed Price Updated: 1:30 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 433,249
Open 1.270
Bid (Size) 1.240 (7)
Ask (Size) 1.250 (24)
Prev. Close 1.260
Today's Range 1.215 - 1.330
52wk Range 0.2425 - 1.470
Shares Outstanding 70,417,345
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Curious about the stocks that are showing activity after the closing bell on Tuesday?
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga

Performance

YTD
+30.0%
+30.0%
1 Month
+28.4%
+28.4%
3 Month
+328.4%
+328.4%
6 Month
+167.1%
+167.1%
1 Year
+6.4%
+6.4%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Top movers in Wednesday's session
Via Chartmill
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
From Ovid Therapeutics Inc.
Via GlobeNewswire
Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
From Ovid Therapeutics Inc.
Via GlobeNewswire
Which stocks are moving after the closing bell on Tuesday?
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Friday's after-hours session.
Via Chartmill
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
From Ovid Therapeutics Inc.
Via GlobeNewswire
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results
From Ovid Therapeutics Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Top movers in Wednesday's after hours session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Top movers in Wednesday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
From Ovid Therapeutics Inc.
Via GlobeNewswire
Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results
From Ovid Therapeutics Inc.
Via GlobeNewswire
Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors
From Ovid Therapeutics Inc.
Via GlobeNewswire
Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
From Ovid Therapeutics Inc.
Via GlobeNewswire
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
From Ovid Therapeutics Inc.
Via GlobeNewswire
Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting
From Ovid Therapeutics Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Ovid Therapeutics Inc. - Common Stock publicly traded?
Yes, Ovid Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Ovid Therapeutics Inc. - Common Stock trade on?
Ovid Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ovid Therapeutics Inc. - Common Stock?
The ticker symbol for Ovid Therapeutics Inc. - Common Stock is OVID on the Nasdaq Stock Market
What is the current price of Ovid Therapeutics Inc. - Common Stock?
The current price of Ovid Therapeutics Inc. - Common Stock is 1.245
When was Ovid Therapeutics Inc. - Common Stock last traded?
The last trade of Ovid Therapeutics Inc. - Common Stock was at 09/15/25 01:30 PM ET
What is the market capitalization of Ovid Therapeutics Inc. - Common Stock?
The market capitalization of Ovid Therapeutics Inc. - Common Stock is 87.67M
How many shares of Ovid Therapeutics Inc. - Common Stock are outstanding?
Ovid Therapeutics Inc. - Common Stock has 88M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.